Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning

[ad_1]

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *